The global therapeutic respiratory devices market size was valued at USD 21.42 billion in 2025 and is projected to grow from USD 22.45 billion in 2026 to USD 32.66 billion by 2034, registering a CAGR of 4.8% during the forecast period from 2026 to 2034. North America dominated the therapeutic respiratory devices market with a market share of 38.6% in 2025.
Therapeutic respiratory devices (TRDs) improve pulmonary function, increase lung oxygenation, and facilitate bronchial mucus removal during respiratory therapy. Increasing the prevalence of chronic respiratory and pulmonary diseases prompts the need for effective therapeutic respirator devices. As per the survey by the Forum of International Respiratory Societies (FIRS), globally, about 100 million adults suffer from a sleep-breathing disorder, more than 235 million people have asthma, and about 200 million are diagnosed with COPD. In developed and developing countries, the incidence rate of respiratory disorders is high due to increasing air pollution and occupational pollutants, and smoking, causing airway inflammation.
Download a Free Sample To learn more about this report,
Increasing Adoption of Advanced Home-Based Respiratory Care
The therapeutic respiratory devices market is witnessing a strong trend toward home-based respiratory care and technologically advanced treatment solutions. The rising prevalence of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and other pulmonary disorders is driving demand for portable and user-friendly respiratory devices. Manufacturers are increasingly integrating digital health technologies, remote patient monitoring, artificial intelligence (AI), and wireless connectivity into therapeutic respiratory devices to improve treatment outcomes, enhance patient compliance, and enable continuous monitoring outside hospital settings. In addition, the growing aging population, increasing air pollution, and rising healthcare expenditure are further accelerating the adoption of advanced respiratory care solutions across home healthcare and clinical settings.
Rising Geriatric Population and Increasing Burden of Chronic Respiratory Diseases
The growing geriatric population and the rising prevalence of chronic respiratory diseases are major factors driving the therapeutic respiratory devices market. Older adults are more susceptible to respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and other pulmonary disorders, increasing the demand for effective respiratory therapy. In addition, rising air pollution, smoking, occupational exposure to harmful pollutants, and changing lifestyles have contributed to a significant increase in respiratory illnesses worldwide. The growing preference for home healthcare, coupled with increasing demand for nebulizers, ventilators, oxygen concentrators, and CPAP devices, is further accelerating market growth. Continuous improvements in healthcare infrastructure and increasing awareness regarding early diagnosis and long-term respiratory disease management are also supporting the adoption of therapeutic respiratory devices.
Low Patient Compliance and Device Usage Challenges
Low patient compliance remains a significant restraint for the therapeutic respiratory devices market. Many patients experience discomfort while using respiratory devices, particularly CPAP machines, ventilators, and oxygen therapy systems, leading to inconsistent treatment adherence. Poor mask fitting, device noise, maintenance requirements, and difficulties in adapting to long-term therapy often discourage regular usage, reducing treatment effectiveness. Additionally, limited awareness regarding proper device handling and inadequate patient training can further affect therapy outcomes. These challenges are particularly evident among elderly patients and individuals requiring long-term respiratory support, limiting the overall adoption of therapeutic respiratory devices.
Technological Advancements in Smart Respiratory Devices
Continuous technological advancements present significant opportunities for the therapeutic respiratory devices market. Manufacturers are increasingly developing lightweight, portable, and intelligent respiratory devices integrated with artificial intelligence (AI), cloud connectivity, Bluetooth, and remote patient monitoring capabilities. These innovations enable healthcare providers to monitor patient health in real time, optimize treatment plans, and improve clinical outcomes through data-driven decision-making. The growing adoption of telehealth services and home-based respiratory care is further encouraging the development of connected respiratory devices that enhance patient convenience while reducing hospital admissions and healthcare costs.
High Cost of Advanced Respiratory Care Devices
The high cost of advanced therapeutic respiratory devices continues to challenge market growth, particularly in developing and low-income regions. Sophisticated ventilators, oxygen concentrators, and connected respiratory monitoring systems often require significant upfront investments and ongoing maintenance costs, making them less accessible for many healthcare facilities and patients. Limited reimbursement coverage in several countries and disparities in healthcare infrastructure further restrict the adoption of advanced respiratory care technologies. These affordability challenges remain a key barrier despite the increasing demand for respiratory disease management solutions.
Positive Airway Pressure Devices Segment Dominated the Market with 26.4% Share in 2025
The positive airway pressure devices segment dominated the therapeutic respiratory devices market with the largest revenue share of 26.4% in 2025. The segment's growth is driven by the increasing prevalence of sleep apnea, chronic obstructive pulmonary disease (COPD), and other chronic respiratory disorders requiring long-term respiratory support. Rising awareness of sleep-related breathing disorders, growing adoption of home healthcare, and continuous advancements in portable and connected PAP devices are further contributing to the segment's dominance.
The market also comprises nebulizers, humidifiers, oxygen concentrators, ventilators, capnography devices, and gas analyzers. These products continue to witness steady demand due to the increasing burden of respiratory diseases, rising hospital admissions, expanding home respiratory care services, and growing investments in advanced respiratory monitoring and treatment technologies.
Request Customizationto receive a tailored report.
HEPA Filter Technology Segment is Expected to Register the Fastest CAGR of 8.9% During the Forecast Period
The HEPA filter technology segment is projected to register the fastest CAGR of 8.9% during the forecast period. The segment's growth is attributed to its superior filtration efficiency in removing airborne particles, allergens, bacteria, and other contaminants, making it highly suitable for respiratory care devices. Increasing concerns regarding airborne infections, rising healthcare standards, and growing demand for advanced filtration technologies in hospitals and home healthcare settings are accelerating the adoption of HEPA filter technology.
The therapeutic respiratory devices market also utilizes electrostatic filtration, hollow fiber filtration, and microsphere separation technologies. These technologies continue to support market growth by improving filtration efficiency, enhancing respiratory device performance, and meeting the evolving clinical requirements for safe and effective respiratory therapy.
Positive Airway Pressure Devices Filter Segment Dominated the Market with 29.8% Share in 2025
The positive airway pressure devices filter segment accounted for the largest revenue share of 29.8% in 2025. The segment's dominance is driven by the increasing global adoption of CPAP and BiPAP devices for the treatment of sleep apnea and other respiratory disorders. Regular replacement of PAP filters to maintain optimal airflow, improve therapy effectiveness, and ensure patient safety continues to generate consistent demand across both healthcare facilities and homecare settings.
The market also includes nebulizer filters, humidifier filters, oxygen concentrator filters, and ventilator filters, each playing a vital role in maintaining device performance and infection control. Growing utilization of respiratory care devices in hospitals, clinics, and home healthcare environments is expected to support steady demand for these filter segments throughout the forecast period.
Speak to an Analystto discuss market opportunities.
North America dominated the therapeutic respiratory devices market with the largest revenue share of 38.6% in 2025 and was valued at USD 8.27 billion. The regional market is driven by the high prevalence of chronic respiratory diseases, well-established healthcare infrastructure, and increasing adoption of advanced respiratory care technologies. Rising demand for home healthcare, favorable reimbursement policies, and continuous investments in digital respiratory monitoring solutions are further supporting the adoption of therapeutic respiratory devices across hospitals and homecare settings.
The United States therapeutic respiratory devices market was valued at USD 6.53 billion in 2025. Market growth is driven by the increasing incidence of chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and other respiratory disorders. Growing adoption of home respiratory care, technological advancements in connected respiratory devices, and rising healthcare expenditure continue to strengthen market expansion.
The Canada therapeutic respiratory devices market was valued at USD 1.74 billion in 2025. The market is supported by an aging population, increasing prevalence of respiratory diseases, and expanding access to advanced respiratory care technologies. Government investments in healthcare infrastructure and growing awareness of home-based respiratory therapy are further contributing to market growth.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe accounted for 29.4% of the global therapeutic respiratory devices market in 2025 and was valued at USD 6.30 billion. The regional market is driven by increasing healthcare expenditure, rising prevalence of respiratory disorders, and strong adoption of advanced respiratory care solutions. The growing elderly population, favorable reimbursement policies, and increasing demand for home healthcare services continue to support market growth across the region.
The Germany therapeutic respiratory devices market was valued at USD 1.91 billion in 2025. Market growth is supported by the country's advanced healthcare system, increasing adoption of respiratory monitoring technologies, and rising demand for innovative respiratory treatment devices. Growing investments in hospital modernization and home healthcare are further driving market expansion.
The United Kingdom therapeutic respiratory devices market was valued at USD 1.49 billion in 2025. Increasing prevalence of asthma and COPD, expanding home respiratory care programs, and continuous technological advancements in respiratory devices are supporting market growth. The country's focus on improving chronic disease management further strengthens demand for therapeutic respiratory devices.
Asia Pacific held 22.7% of the global therapeutic respiratory devices market in 2025 and was valued at USD 4.86 billion. The regional market is expected to witness significant growth due to increasing air pollution, a rapidly aging population, expanding healthcare infrastructure, and rising awareness of respiratory disease management. Growing investments in healthcare facilities and increasing adoption of advanced respiratory care technologies are further accelerating market growth.
The China therapeutic respiratory devices market was valued at USD 2.03 billion in 2025. Market growth is driven by rising incidences of respiratory diseases, expanding healthcare infrastructure, and increasing investments in medical device manufacturing. Government initiatives to improve healthcare accessibility and growing demand for home respiratory care are further supporting market expansion.
The Japan therapeutic respiratory devices market was valued at USD 1.14 billion in 2025. The market is supported by the country's aging population, increasing prevalence of chronic respiratory disorders, and widespread adoption of advanced respiratory care technologies. Rising demand for home healthcare and connected respiratory devices continues to contribute to market growth.
Latin America accounted for 5.4% of the global therapeutic respiratory devices market in 2025 and was valued at USD 1.16 billion. The regional market is driven by increasing healthcare investments, growing awareness of respiratory disease management, and expanding access to medical devices. Rising prevalence of chronic respiratory disorders and improving healthcare infrastructure are expected to support steady market growth.
The Brazil therapeutic respiratory devices market was valued at USD 0.59 billion in 2025. Increasing healthcare expenditure, rising prevalence of asthma and COPD, and growing adoption of home respiratory care solutions are driving market growth. Government initiatives to strengthen healthcare services are further supporting demand for therapeutic respiratory devices.
The Middle East and Africa accounted for 3.9% of the global therapeutic respiratory devices market in 2025 and were valued at USD 0.84 billion. The regional market is driven by increasing healthcare investments, growing burden of respiratory diseases, and expanding access to advanced medical technologies. Rising awareness of respiratory health and ongoing improvements in healthcare infrastructure are expected to support market growth during the forecast period.
The UAE therapeutic respiratory devices market was valued at USD 0.27 billion in 2025. Market growth is supported by rising healthcare expenditure, increasing adoption of advanced respiratory care technologies, and growing demand for home healthcare services. Continuous investments in modern healthcare infrastructure and chronic disease management programs are further driving the adoption of therapeutic respiratory devices.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Associate
Dhanshee Bhapkar is a healthcare research professional with 4+ years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.
Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.
Assisted Walking Devices Market Size, Share, Growth, 2034
Spirometer Market Size, Share, Growth, Analysis, Report, 2034
Vessel Sealing Devices Market Size, Share, Growth, Analysis, 2034
ECG Patch and Holter Monitor Market Size, Share, Growth, 2034
Tampon Market Size, Share, Growth, Opportunities, Analysis, 2034
Artificial Cornea and Corneal Implant Market Size, Share, 2034
We are featured on:
sales@straitsresearch.com